Regenerative Medicine Market:
Regenerative medicine is a segment of translational research in molecular biology and tissue engineering. It involves the process of regeneration of human cells, tissues, or organs to re-establish their normal functions through stimulation of body’s repair system. They are widely used in the treatment of many degenerative disorders occurring in the areas of dermatology, orthopedic, cardiovascular and neurodegenerative diseases. Stem cell therapy is the available tool in the field of translational regenerative medicine.
It has gained importance in the past few years as it is a bio-based alternative to synthetic options. Stem cells have high power of regeneration. Hence, these enable production of other cells in the body. This has increased demand for stem cell therapy in the treatment of degenerative diseases. Currently, stem cell therapy has applications in the treatment of diseases such as autism, cancer, retinal diseases, heart failure, diabetes, rheumatoid arthritis, Alzheimer’s. Extensive research is being carried out on stem cell therapy. The Centre for Commercialization of Regenerative Medicine (CCRM) has reported around 1900 active clinical trials undergoing currently. It also reported 574 active industry-sponsored cell therapy clinical studies, 50 of these are in phase 3 development. Hence, stem cell therapy is projected to contribute to the growth of the translational regenerative medicine market. However, ethical issues in the use of embryonic stem cells is likely to restrain the market.
Rising prevalence of degenerative diseases, aging population, rapid growth of emerging countries, and technical advancements in developed countries are the major factors fueling the growth of the translational regenerative medicine market.
The global translational regenerative medicine market has been segmented based on product type, therapy, application, and region. In terms of product type, the market has been categorized into cellular and acellular. The cellular segment dominated the global market in 2016. Based on therapy, the global translational regenerative market has been segmented into cell therapy, gene therapy, immunotherapy, and tissue engineering.
In terms of application, the market has been segmented into orthopedic & musculoskeletal, cardiology, diabetes, central nervous system diseases, dermatology, and others. Cardiology and orthopedic & musculoskeletal are anticipated to be the fastest growing segments of the global translational regenerative medicine market.
In terms of region, the global translational regenerative medicine market has been segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America dominated the global regenerative medicine market owing to a large number of leading companies and expansion of research and development activities in the U.S.
Increased medical reimbursement and advanced health care also drive the market in the region. Orthopedic is the leading application segment contributing to the growth of the market in the region. Asia Pacific is forecasted the huge growth because of large consumer pool, rising income, and health care expenditure. However, the market in Asia Pacific could face challenges such as high cost of bio-based medicines and stringent regulatory policies.
The Glory Wellness & Regenerative Centre with clinics in United States (U.S.), Lagos and Abuja is wooing the Nigerian Institute for Medical Research (NIMR) Yaba, Lagos for clinical trails using stem cell therapy to treat chronic diseases.
Until now, physicians all over the world are increasingly employing stem cell therapies for the treatment of chronic diseases including Human Immuno-deficiency Virus (HIV), hypertension, diabetes, chronic kidney disease, neurological disorders, asthma, diabetes, rheumatoid arthritis, spinal cord injuries, female and male sexual dysfunction, joint pain and autoimmune disease.
One of the pioneers of stem cell therapy in Nigeria and the Medical Director of Glory Wellness & Regenerative Centre, Dr. David Ikudayisi, told The Guardian: “I started preliminary talk late last year with NIMR in Yaba about doing research on treating advanced solid tumours including metastatic cancers using the combination of the currently proven safe adult stem cell therapy and a currently proven safe drug/medication. In USA, combining two independently safe procedures or drugs for new indications require clinical trials”.
Today, we have a Regenrative medicine product here in Nigeria.
Health Based Networking Coach
I help people to achieve complete health through innovative and advanced health practices and products that are scientifically proven, evidently seen and biblically supported. Through effective network building, I help people create value to impact their generation and be visible and financially stable. I am Your no.1 Health Base Networking coach.